4-(4-氯苯基)哌啶-4-甲腈结构式
|
常用名 | 4-(4-氯苯基)哌啶-4-甲腈 | 英文名 | 4-(4-Chlorophenyl)piperidine-4-carbonitrile |
---|---|---|---|---|
CAS号 | 91721-16-3 | 分子量 | 220.698 | |
密度 | 1.2±0.1 g/cm3 | 沸点 | 370.1±42.0 °C at 760 mmHg | |
分子式 | C12H13ClN2 | 熔点 | N/A | |
MSDS | N/A | 闪点 | 177.6±27.9 °C |
中文名 | 4-(4-氯苯基)哌啶-4-甲腈 |
---|---|
英文名 | 4-(4-chlorophenyl)piperidine-4-carbonitrile |
英文别名 | 更多 |
密度 | 1.2±0.1 g/cm3 |
---|---|
沸点 | 370.1±42.0 °C at 760 mmHg |
分子式 | C12H13ClN2 |
分子量 | 220.698 |
闪点 | 177.6±27.9 °C |
精确质量 | 220.076721 |
PSA | 35.82000 |
LogP | 2.07 |
蒸汽压 | 0.0±0.8 mmHg at 25°C |
折射率 | 1.580 |
储存条件 | 2-8°C,避光,保存于惰性气体中 |
海关编码 | 2933399090 |
---|
~97% 4-(4-氯苯基)哌啶-4-甲腈 91721-16-3 |
文献:ASTEX THERAPEUTICS LIMITED; THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL; ASTRAZENECA AB Patent: WO2006/136829 A2, 2006 ; Location in patent: Page/Page column 119-120 ; WO 2006/136829 A2 |
~% 4-(4-氯苯基)哌啶-4-甲腈 91721-16-3 |
文献:GLAXO GROUP LIMITED Patent: WO2004/5256 A2, 2004 ; Location in patent: Page 34 ; WO 2004/005256 A2 |
~% 4-(4-氯苯基)哌啶-4-甲腈 91721-16-3 |
文献:ChemoCentryx, Inc. Patent: US2007/88036 A1, 2007 ; Location in patent: Page/Page column 16 ; US 20070088036 A1 |
海关编码 | 2933399090 |
---|---|
中文概述 | 2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
4-Piperidinecarbonitrile, 4-(4-chlorophenyl)- |
4-(4-chlorophenyl)-4-cyanopiperidine |
4-(4-chloro-phenyl)-piperidine-4-carbonitrile |
4-Piperidinecarbonitrile,4-(4-chlorophenyl) |
4-(4-Chlorophenyl)-4-piperidinecarbonitrile |